A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

PHASE3CompletedINTERVENTIONAL

Enrollment

419

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

August 31, 2014

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

ABT-450/r/ABT-267, ABT-333

Tablet; ABT-450 coformulated with ritonavir and ABT-267, ABT-333 tablet

DRUG

Ribavirin

Capsule

DRUG

Placebo for ribavirin

Capsule

All Listed Sponsors

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01767116 - A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection | Biotech Hunter | Biotech Hunter